These results indicated that IL-6 and IL-10 were increased at the beginning of COVID-19 infection, but their levels decreased during treatment and correlated with disease outcome; thus, these two cytokines might serve as early diagnostic and prognostic markers of COVID-19. The gene discussed is IL6; the disease is COVID-19.